December 4th, 2007

SpeculatingStocks.com Stock Pick: NMT Medical, Inc. (NMTI)

Price: $5.78 (long-term)

NMT Medical, Inc. is an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedure.

Recent research has linked an anomaly of the heart to migraines. The anomoly of the heart that is believed to be linked to migraines is patent foramen ovale (PFO), a small opening between two overlapping sections of tissue between the right atrium and left atrium.

NMTI has developed and is studying its MIST II (Migraine Intervention with BioSTAR®) using a septal repair implant. The implants purpose is to close the small opening caused by PFO and possibly prove to be an effective treatment for patients suffering from migraines with auras.

Based upon two year animal research data and the BioSTAR® Evaulation Study, currently published in the Journal of the American Heart Association, 92% closure occurred at 30 days and 96% closure at 6 months. The MIST II randomizatiom for clinical trials commenced in October.

As of September 30, 2007, the company had $33.61 million in cash and marketeble securities to fund ongoing BioSTAR® clinical trials for multiple uses. NMTI currently has no long-term debt.